Detalhe da pesquisa
1.
PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMI.
Circ Res
; 120(2): 324-331, 2017 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27821724
2.
Surgical decompression of arachnoid cysts leads to improved quality of life: a prospective study-long-term follow-up.
Acta Neurochir (Wien)
; 161(11): 2253-2263, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31385039
3.
Small-molecule histone methyltransferase inhibitors display rapid antimalarial activity against all blood stage forms in Plasmodium falciparum.
Proc Natl Acad Sci U S A
; 109(41): 16708-13, 2012 Oct 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-23011794
4.
Catalytic asymmetric alkylation reactions for the construction of protected ethylene-amino and propylene-amino motifs attached to quaternary stereocentres.
Chemistry
; 19(9): 3071-81, 2013 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-23335289
5.
Case Report: Limbic encephalitis following treatment with durvalumab for small-cell lung cancer.
Front Immunol
; 14: 1278761, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37908347
6.
Discovery and Optimization of the First ATP Competitive Type-III c-MET Inhibitor.
J Med Chem
; 66(13): 8782-8807, 2023 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37343272
7.
The Next-Generation Oral Selective Estrogen Receptor Degrader Camizestrant (AZD9833) Suppresses ER+ Breast Cancer Growth and Overcomes Endocrine and CDK4/6 Inhibitor Resistance.
Cancer Res
; 83(23): 3989-4004, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37725704
8.
Discovery of a Potent and Orally Bioavailable Zwitterionic Series of Selective Estrogen Receptor Degrader-Antagonists.
J Med Chem
; 66(4): 2918-2945, 2023 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36727211
9.
Actual and projected gaps in the provision of residential aged care in New South Wales, Australia.
Aust Health Rev
; 46(4): 398-404, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34711302
10.
Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models.
J Med Chem
; 65(4): 3306-3331, 2022 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35133824
11.
CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent.
Am Heart J
; 161(1): 98-105, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21167340
12.
An efficient, stereocontrolled and versatile synthetic route to bicyclic partially saturated privileged scaffolds.
Chem Commun (Camb)
; 56(50): 6818-6821, 2020 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32432281
13.
Addition of Fluorine and a Late-Stage Functionalization (LSF) of the Oral SERD AZD9833.
ACS Med Chem Lett
; 11(12): 2519-2525, 2020 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33335676
14.
Discovery of AZD9833, a Potent and Orally Bioavailable Selective Estrogen Receptor Degrader and Antagonist.
J Med Chem
; 63(23): 14530-14559, 2020 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32910656
15.
Building Bridges in a Series of Estrogen Receptor Degraders: An Application of Metathesis in Medicinal Chemistry.
ACS Med Chem Lett
; 10(10): 1492-1497, 2019 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31620239
16.
Tricyclic Indazoles-A Novel Class of Selective Estrogen Receptor Degrader Antagonists.
J Med Chem
; 62(3): 1593-1608, 2019 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30640465
17.
Enantio- and diastereoselective catalytic alkylation reactions with aziridines.
J Am Chem Soc
; 130(31): 10076-7, 2008 Aug 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-18616245
18.
Efficient base catalyzed alkylation reactions with aziridine electrophiles.
Chem Commun (Camb)
; (21): 2474-6, 2008 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-18491019
19.
Platelet-Derived Mitochondria Display Embryonic Stem Cell Markers and Improve Pancreatic Islet ß-cell Function in Humans.
Stem Cells Transl Med
; 6(8): 1684-1697, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28685960
20.
Tetrahydroisoquinoline Phenols: Selective Estrogen Receptor Downregulator Antagonists with Oral Bioavailability in Rat.
ACS Med Chem Lett
; 7(1): 94-9, 2016 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26819673